Английская Википедия:ERB-196
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Drugbox
ERB-196, also known as WAY-202196, is a synthetic nonsteroidal estrogen that acts as a highly selective agonist of the ERβ.[1][2][3][4][5][6] It possesses 78-fold selectivity for the ERβ over the ERα.[1] The drug was under development by Wyeth for the treatment of inflammation and sepsis starting in 2004 but development was discontinued by 2011.[2][7]
See also
References
External links
Шаблон:Estrogen receptor modulators
Шаблон:Genito-urinary-drug-stub